& Szczepanik, M
FDA has issued warnings regarding adverse events associated with compounded injectable glutathione, specifically noting nausea, vomiting, and difficulty breathing as documented concerns
About the prescription of exenatide and liraglutide, both compounds are contraindicated in MTC patients or multiple endocrine neoplasia syndrome 2 (MEN 2) patients due to the increased incidence of C-cell hyperplasia and tumors combined with elevated calcitonin levels in preclinical studies in rodents
In the interest of providing a balanced comparison, there are scenarios where Mochi Health may be the right choice: Brand-name preference: If you specifically want access to FDA-approved, brand-name GLP-1 medications (Wegovy, Ozempic, Mounjaro) and are willing to pay the premium, Mochi Health offers both compounded and brand-name options
Dig Dis Sci 69(12):44374445 [DOI] [PubMed] [Google Scholar] 12.Anson M, Henney AE, Broadwell N et al (2024) Incidence of new onset type 2 diabetes in adults living with obesity treated with Tirzepatide or semaglutide: real world evidence from an international retrospective cohort study
J Infect